Jiangsu Recbio Technology Balance Sheet Health
Financial Health criteria checks 3/6
Jiangsu Recbio Technology has a total shareholder equity of CN¥1.1B and total debt of CN¥631.6M, which brings its debt-to-equity ratio to 59%. Its total assets and total liabilities are CN¥2.2B and CN¥1.1B respectively.
Key information
59.0%
Debt to equity ratio
CN¥631.64m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥837.76m |
| Equity | CN¥1.07b |
| Total liabilities | CN¥1.12b |
| Total assets | CN¥2.19b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 2179's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥444.2M).
Long Term Liabilities: 2179's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥671.1M).
Debt to Equity History and Analysis
Debt Level: 2179 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2179's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2179 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 2179 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.6% each year